{
  "issues": [
    "Renal tool output contains contradictory assessments: it flags creatinine as 'fail' despite a value (1.7 mg/dL) that is only modestly elevated and an eGFR of 59 mL/min/1.73m² which the tool itself marks as a 'pass'.",
    "Renal tool summary lists \"Missing BMI or creatinine\" and \"No lab timestamps provided\" even though creatinine is present and timestamps are included for each check.",
    "Agent 2 recommends a CT Pulmonary Angiography (CTA) without addressing the patient's significant hypotension (MAP 59 mmHg) which increases the risk of contrast‑induced nephropathy and may contraindicate immediate contrast administration.",
    "Agent 2 includes an irrelevant carotid CTA protocol in the selection output, which does not pertain to the current clinical question.",
    "No explicit plan for managing the patient’s low blood pressure before contrast administration is provided."
  ],
  "recommendations": [
    "Re‑evaluate the necessity of CTA PE: assess clinical probability (e.g., Wells score) and consider alternative imaging (ventilation‑perfusion scan) if PE suspicion is low or if the patient cannot tolerate contrast due to hypotension.",
    "If CTA is deemed essential, implement renal protective measures: pre‑hydrate with isotonic saline (e.g., 1 mL/kg/hr for 6–12 hours) unless contraindicated by cardiac status, and use low‑osmolar or iso‑osmolar contrast at the minimal effective volume (≈80–100 mL).",
    "Consider a reduced contrast dose or split‑dose protocol, and employ automated injector with a lower injection rate to lessen peak renal exposure.",
    "Monitor hemodynamics closely: stabilize MAP > 65 mmHg before contrast (e.g., with cautious fluid bolus or vasopressor support) to mitigate prerenal azotemia risk.",
    "Obtain baseline renal labs immediately before the study and repeat serum creatinine 24–48 hours post‑procedure to detect contrast‑induced nephropathy early.",
    "Document a clear justification for contrast use in the electronic health record, referencing the emergent nature of the suspected PE and the renal protection strategy.",
    "Remove the carotid CTA protocol from the recommendation list as it is not relevant to the current indication."
  ],
  "confidence": 0.68,
  "agent2_confidence": 0.62,
  "timestamp": "2025-09-08T17:20:14.827000Z",
  "tool_outputs": {
    "renal": {
      "tool_id": "renal_tool_v2",
      "checks": [
        {
          "id": "egfr_ckd_epi",
          "units": "ml/min/1.73m2",
          "timestamp": "2025-09-08T17:20:11.161113Z",
          "priority": "critical",
          "value": 59.0,
          "status": "pass",
          "reason": "Low renal risk for contrast."
        },
        {
          "id": "creatinine_mg_dl",
          "units": "mg/dL",
          "timestamp": "2025-09-08T17:20:11.161153Z",
          "priority": "critical",
          "value": 1.7,
          "status": "fail",
          "reason": "Creatinine significantly elevated."
        },
        {
          "id": "bun_creatinine_ratio",
          "timestamp": "2025-09-08T17:20:11.161173Z",
          "priority": "important",
          "value": 20.0,
          "status": "warning",
          "reason": "BUN/Cr ratio suggests prerenal azotemia."
        },
        {
          "id": "potassium_mmol_l",
          "units": "mEq/L",
          "timestamp": "2025-09-08T17:20:11.161202Z",
          "priority": "important",
          "value": 4.6,
          "status": "pass",
          "reason": "Potassium normal."
        }
      ],
      "summary": {
        "overall": "fail",
        "reasons": [
          "Creatinine significantly elevated.",
          "BUN/Cr ratio suggests prerenal azotemia.",
          "Missing BMI or creatinine.",
          "No lab timestamps provided."
        ],
        "confidence": 0.52
      },
      "metadata": {
        "version": "2.0.0",
        "run_ts": "2025-09-08T17:20:11.161291Z"
      }
    }
  },
  "llm_raw": "{\n  \"issues\": [\n    \"Renal tool output contains contradictory assessments: it flags creatinine as 'fail' despite a value (1.7 mg/dL) that is only modestly elevated and an eGFR of 59 mL/min/1.73m² which the tool itself marks as a 'pass'.\",\n    \"Renal tool summary lists \\\"Missing BMI or creatinine\\\" and \\\"No lab timestamps provided\\\" even though creatinine is present and timestamps are included for each check.\",\n    \"Agent 2 recommends a CT Pulmonary Angiography (CTA) without addressing the patient's significant hypotension (MAP 59 mmHg) which increases the risk of contrast‑induced nephropathy and may contraindicate immediate contrast administration.\",\n    \"Agent 2 includes an irrelevant carotid CTA protocol in the selection output, which does not pertain to the current clinical question.\",\n    \"No explicit plan for managing the patient’s low blood pressure before contrast administration is provided.\"\n  ],\n  \"recommendations\": [\n    \"Re‑evaluate the necessity of CTA PE: assess clinical probability (e.g., Wells score) and consider alternative imaging (ventilation‑perfusion scan) if PE suspicion is low or if the patient cannot tolerate contrast due to hypotension.\",\n    \"If CTA is deemed essential, implement renal protective measures: pre‑hydrate with isotonic saline (e.g., 1 mL/kg/hr for 6–12 hours) unless contraindicated by cardiac status, and use low‑osmolar or iso‑osmolar contrast at the minimal effective volume (≈80–100 mL).\",\n    \"Consider a reduced contrast dose or split‑dose protocol, and employ automated injector with a lower injection rate to lessen peak renal exposure.\",\n    \"Monitor hemodynamics closely: stabilize MAP > 65 mmHg before contrast (e.g., with cautious fluid bolus or vasopressor support) to mitigate prerenal azotemia risk.\",\n    \"Obtain baseline renal labs immediately before the study and repeat serum creatinine 24–48 hours post‑procedure to detect contrast‑induced nephropathy early.\",\n    \"Document a clear justification for contrast use in the electronic health record, referencing the emergent nature of the suspected PE and the renal protection strategy.\",\n    \"Remove the carotid CTA protocol from the recommendation list as it is not relevant to the current indication.\"\n  ],\n  \"confidence\": 0.78\n}",
  "hallucination_analysis": {
    "statement_assessments": [
      {
        "text": "Renal tool output contains contradictory assessments: it flags creatinine as 'fail' despite a value (1.7 mg/dL) that is only modestly elevated and an eGFR of 59 mL/min/1.73m² which the tool itself marks as a 'pass'.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact '1.7'"
      },
      {
        "text": "Renal tool summary lists \"Missing BMI or creatinine\" and \"No lab timestamps provided\" even though creatinine is present and timestamps are included for each check.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 recommends a CT Pulmonary Angiography (CTA) without addressing the patient's significant hypotension (MAP 59 mmHg) which increases the risk of contrast‑induced nephropathy and may contraindicate immediate contrast administration.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Agent 2 includes an irrelevant carotid CTA protocol in the selection output, which does not pertain to the current clinical question.",
        "type": "issue",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "No explicit plan for managing the patient’s low blood pressure before contrast administration is provided.",
        "type": "issue",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Re‑evaluate the necessity of CTA PE: assess clinical probability (e.g., Wells score) and consider alternative imaging (ventilation‑perfusion scan) if PE suspicion is low or if the patient cannot tolerate contrast due to hypotension.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "If CTA is deemed essential, implement renal protective measures: pre‑hydrate with isotonic saline (e.g., 1 mL/kg/hr for 6–12 hours) unless contraindicated by cardiac status, and use low‑osmolar or iso‑osmolar contrast at the minimal effective volume (≈80–100 mL).",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact '100'"
      },
      {
        "text": "Consider a reduced contrast dose or split‑dose protocol, and employ automated injector with a lower injection rate to lessen peak renal exposure.",
        "type": "recommendation",
        "classification": "unverified",
        "rationale": "no direct or inferred support found"
      },
      {
        "text": "Monitor hemodynamics closely: stabilize MAP > 65 mmHg before contrast (e.g., with cautious fluid bolus or vasopressor support) to mitigate prerenal azotemia risk.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Obtain baseline renal labs immediately before the study and repeat serum creatinine 24–48 hours post‑procedure to detect contrast‑induced nephropathy early.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Document a clear justification for contrast use in the electronic health record, referencing the emergent nature of the suspected PE and the renal protection strategy.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      },
      {
        "text": "Remove the carotid CTA protocol from the recommendation list as it is not relevant to the current indication.",
        "type": "recommendation",
        "classification": "supported",
        "rationale": "matches known fact 'f'"
      }
    ],
    "counts": {
      "supported": 10,
      "inferred": 0,
      "domain_safe": 0,
      "unverified": 2,
      "contradicted": 0
    },
    "hallucination_score": 0.083,
    "recommendation": {
      "force_revision": false,
      "confidence_reduction": 0.1
    },
    "knowledge_base_summary": {
      "numbers": {
        "subject_id": 20028931.0,
        "age": 72.0,
        "hadm_id": 34567891.0,
        "creatinine_mg_dl": 1.7,
        "bun_mg_dl": 34.0,
        "glucose_mg_dl": 142.0,
        "hemoglobin_g_dl": 10.1,
        "hematocrit_pct": 30.5,
        "platelet_count": 210.0,
        "wbc_count": 12.3,
        "sodium_meq_l": 135.0,
        "potassium_mmol_l": 4.6,
        "chloride_meq_l": 100.0,
        "bicarbonate_meq_l": 21.0,
        "egfr_ckd_epi": 59.0,
        "heart_rate_bpm": 95.0,
        "systolic_bp_mmhg": 82.0,
        "diastolic_bp_mmhg": 48.0,
        "map_mmhg": 59.0,
        "pulse_pressure_mmhg": 34.0,
        "temperature_f": 98.9,
        "spo2_pct": 94.0,
        "respiratory_rate": 22.0,
        "bun_creatinine_ratio": 20.0,
        "hospital_expire_flag": 0.0,
        "data_completeness_pct": 0.95
      },
      "raw_strings_sample": [
        "72",
        "bun_creatinine_ratio",
        "potassium normal.",
        "white",
        "creatinine_mg_dl",
        "210",
        "20",
        "1.7",
        "20.0",
        "34567891"
      ]
    }
  },
  "feedback": {
    "issues": [
      "Renal tool output contains contradictory assessments: it flags creatinine as 'fail' despite a value (1.7 mg/dL) that is only modestly elevated and an eGFR of 59 mL/min/1.73m² which the tool itself marks as a 'pass'.",
      "Renal tool summary lists \"Missing BMI or creatinine\" and \"No lab timestamps provided\" even though creatinine is present and timestamps are included for each check.",
      "Agent 2 recommends a CT Pulmonary Angiography (CTA) without addressing the patient's significant hypotension (MAP 59 mmHg) which increases the risk of contrast‑induced nephropathy and may contraindicate immediate contrast administration.",
      "Agent 2 includes an irrelevant carotid CTA protocol in the selection output, which does not pertain to the current clinical question.",
      "No explicit plan for managing the patient’s low blood pressure before contrast administration is provided."
    ],
    "recommendations": [
      "Re‑evaluate the necessity of CTA PE: assess clinical probability (e.g., Wells score) and consider alternative imaging (ventilation‑perfusion scan) if PE suspicion is low or if the patient cannot tolerate contrast due to hypotension.",
      "If CTA is deemed essential, implement renal protective measures: pre‑hydrate with isotonic saline (e.g., 1 mL/kg/hr for 6–12 hours) unless contraindicated by cardiac status, and use low‑osmolar or iso‑osmolar contrast at the minimal effective volume (≈80–100 mL).",
      "Consider a reduced contrast dose or split‑dose protocol, and employ automated injector with a lower injection rate to lessen peak renal exposure.",
      "Monitor hemodynamics closely: stabilize MAP > 65 mmHg before contrast (e.g., with cautious fluid bolus or vasopressor support) to mitigate prerenal azotemia risk.",
      "Obtain baseline renal labs immediately before the study and repeat serum creatinine 24–48 hours post‑procedure to detect contrast‑induced nephropathy early.",
      "Document a clear justification for contrast use in the electronic health record, referencing the emergent nature of the suspected PE and the renal protection strategy.",
      "Remove the carotid CTA protocol from the recommendation list as it is not relevant to the current indication."
    ],
    "confidence": 0.68
  }
}